TABLE OF CONTENTS
Volume 37, Issue 4 (February (2) 2006)
Original Articles
Conditioning Regimens
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS) FREE
N Kröger, A Shimoni, T Zabelina, H Schieder, J Panse, F Ayuk, C Wolschke, H Renges, J Dahlke, D Atanackovic, A Nagler and A Zander
Bone Marrow Transplant 37: 339-344; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705259
Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation FREE
H Takama, H Tanaka, D Nakashima, R Ueda and Y Takaue
Bone Marrow Transplant 37: 345-351; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705252
A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis FREE
R Nakamura, S Chakrabarti, C Akin, J Robyn, E Bahceci, A Greene, R Childs, C E Dunbar, D D Metcalfe and A J Barrett
Bone Marrow Transplant 37: 353-358; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705245
Cord Blood Stem Cells
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells FREE
S N Robinson, J Ng, T Niu, H Yang, J D McMannis, S Karandish, I Kaur, P Fu, M Del Angel, R Messinger, F Flagge, M de Lima, W Decker, D Xing, R Champlin and E J Shpall
Bone Marrow Transplant 37: 359-366; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705258
Autografting
Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis FREE
E Jantunen, M Itälä, E Juvonen, S Leppä, L Keskinen, K Vasala, K Remes, T Wiklund, E Elonen and T Nousiainen
Bone Marrow Transplant 37: 367-372; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705266
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial FREE
C Harter, B Schulze, H Goldschmidt, A Benner, H K Geiss, T Hoppe-Tichy, A D Ho and G Egerer
Bone Marrow Transplant 37: 373-379; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705256
Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients FREE
S Terakura, M Murata, T Nishida, N Emi, Y Akatsuka, Y Morishima, Y Kodera and T Naoe
Bone Marrow Transplant 37: 381-386; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705257
A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation FREE
H Wandt, K Schaefer-Eckart, M Frank, J Birkmann and M Wilhelm
Bone Marrow Transplant 37: 387-392; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705246
Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT) FREE
P J Stiff, H Erder, W I Bensinger, C Emmanouilides, T Gentile, J Isitt, Z J Lu and R Spielberger
Bone Marrow Transplant 37: 393-401; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705250
Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients FREE
M L Grazziutti, L Dong, M H Miceli, M Cottler-Fox, S G Krishna, A Fassas, F van Rhee, B M Barlogie and E J Anaissie
Bone Marrow Transplant 37: 403-409; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705251
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen FREE
P Frère, F Baron, C Bonnet, K Hafraoui, M Pereira, E Willems, G Fillet and Y Beguin
Bone Marrow Transplant 37: 411-418; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705255
Graft-Versus-Tumor Effects
Increased acute GvHD and higher transplant-related mortality in non-caucasians undergoing standard sibling allogeneic stem cell transplantation FREE
M Karanth, G Begum, M Cook, S Lawson, C Porter, N Lister, J Gray, P Darbyshire, C Craddock and P Mahendra
Bone Marrow Transplant 37: 419-423; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705260
NK Cell Neoplasms
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms FREE
R Suzuki, J Suzumiya, S Nakamura, Y Kagami, J-I Kameoka, C Sakai, H Mukai, K Takenaka, T Yoshino, T Tsuzuki, H Sugimori, K Kawa, Y Kodera and K Oshimi
Bone Marrow Transplant 37: 425-431; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705244
Letters to the Editor
Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient FREE
M Markiewicz, J Wojnar, S Giebel, A Wieczorkiewicz, I Wyle
o
and J Hoowiecki
Bone Marrow Transplant 37: 433-434; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705254
Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient FREE
M Akay, E Gunduz and Z Gulbas
Bone Marrow Transplant 37: 435-436; advance online publication, January 16, 2006; doi:10.1038/sj.bmt.1705261
